Cargando…

Evaluation of the efficacy of cisplatin–etoposide and the role of thoracic radiotherapy and prophylactic cranial irradiation in LCNEC

In small-cell lung cancer (SCLC), the role of chemotherapy and radiotherapy is well established. Large-cell neuroendocrine carcinoma (LCNEC) shares several clinicopathological features with SCLC, but its optimal therapy is not defined. We evaluated clinical response and survival outcomes of advanced...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prelaj, Arsela, Rebuzzi, Sara Elena, Del Bene, Gabriella, Giròn Berrìos, Julio Rodrigo, Emiliani, Alessandra, De Filippis, Lucilla, Prete, Alessandra Anna, Pecorari, Silvia, Manna, Gaia, Ferrara, Carla, Rossini, Daniele, Longo, Flavia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370316/ https://www.ncbi.nlm.nih.gov/pubmed/28382303 http://dx.doi.org/10.1183/23120541.00128-2016

Ejemplares similares

Multimodal treatment for local recurrent malignant gliomas: Resurgery and/or reirradiation followed by chemotherapy
por: Prelaj, Arsela, et al.
Publicado: (2019)

Merkel Cell Carcinoma of the Retroperitoneum with No Identifiable Primary Site
por: Rossini, Daniele, et al.
Publicado: (2013)

Large cell neuroendocrine carcinoma (LCNEC) of the urinary bladder: a case report
por: Colarossi, Cristina, et al.
Publicado: (2013)

Non-conventional fotemustine schedule as second-line treatment in recurrent malignant gliomas: Survival across disease and treatment subgroup analysis and review of the literature
por: Prelaj, Arsela, et al.
Publicado: (2019)

Prophylactic cranial irradiation in SCLC
por: Suwinski, Rafal
Publicado: (2021)

Novel patterns of progression upon immunotherapy in other thoracic malignancies and uncommon populations
por: Ferrara, Roberto, et al.
Publicado: (2021)

DLL3 expression is a predictive marker of sensitivity to adjuvant chemotherapy for pulmonary LCNEC
por: Ogawa, Hiroyuki, et al.
Publicado: (2020)

Pulmonary large cell neuroendocrine carcinoma (LCNEC) with confirmed liver metastases negative on (18)F-FDG and (68)Ga-DOTATATE PET
por: Ninatti, Gaia, et al.
Publicado: (2020)

Molecular mechanisms of etoposide
por: Montecucco, Alessandra, et al.
Publicado: (2015)

Large-cell neuroendocrine carcinoma (LCNEC) without pulmonary symptoms diagnosed in a cutaneous metastasis
por: Yuan, Cai, et al.
Publicado: (2014)

An unusual presentation of multiple cavitated lung metastases from colon carcinoma
por: Seminara, Patrizia, et al.
Publicado: (2011)

Radium-223 in patients with metastatic castration-resistant prostate cancer: Efficacy and safety in clinical practice
por: Prelaj, Arsela, et al.
Publicado: (2019)

Molecular predictors of EGFR-mutant NSCLC transformation into LCNEC after frontline osimertinib: digging under the surface
por: Belluomini, L., et al.
Publicado: (2021)

Treatment of Advanced-Stage Large Cell Neuroendocrine Cancer (LCNEC) of the Lung: A Tale of Two Diseases
por: Atieh, Tahani, et al.
Publicado: (2021)

Is the sum of positive neuroendocrine immunohistochemical stains useful for diagnosis of large cell neuroendocrine carcinoma (LCNEC) on biopsy specimens?
por: Derks, Jules L, et al.
Publicado: (2019)

Dramatic response to alectinib in an ALK ‐positive LCNEC patient with a poor performance status: A case report
por: Masuda, Kazuki, et al.
Publicado: (2021)

Classification of subtypes including LCNEC in lung cancer biopsy slides using convolutional neural network from scratch
por: Yang, Jung Wook, et al.
Publicado: (2022)

Neoadjuvant Chemotherapy in Neuroendocrine Bladder Cancer: A Case Report
por: Prelaj, Arsela, et al.
Publicado: (2016)

Successful treatment of triple EGFR mutation T785A/L861Q/H297_E298 with afatinib
por: Longo, Vito, et al.
Publicado: (2021)

Simultaneous integrated prophylactic cranial irradiation in sino-nasal cancer
por: Jensen, Kenneth, et al.
Publicado: (2017)

Prognostic significance of YAP1 expression and its association with neuroendocrine markers in resected pulmonary large cell neuroendocrine carcinoma (LCNEC)
por: Sun, Xujie, et al.
Publicado: (2022)

Randomized comparison of etoposide pharmacokinetics after oral etoposide phosphate and oral etoposide.
por: de Jong, R. S., et al.
Publicado: (1997)

Prophylactic cranial irradiation in breast cancer: A new way forward
por: Gandhi, Ajeet Kumar, et al.
Publicado: (2015)

Self-Reported Cognitive Function and Quality of Life in Patients With SCLC in the Hippocampal Avoidance Prophylactic Cranial Irradiation Versus Prophylactic Cranial Irradiation Randomized Phase 3 Trial (NCT01780675)
por: Albers, Elaine A.C., et al.
Publicado: (2023)

Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer
por: Rebuzzi, Sara Elena, et al.
Publicado: (2021)

Small cell bladder cancer: should we consider prophylactic cranial irradiation?
por: Morgan, Tara Nikonow, et al.
Publicado: (2019)

Conversion of the prodrug etoposide phosphate to etoposide in gastric juice and bile.
por: de Jong, R. S., et al.
Publicado: (1997)

Biodistribution of etoposide via intratumoral chemotherapy with etoposide-loaded implants
por: Wu, Chunsheng, et al.
Publicado: (2020)

The Prevention of Brain Metastases in Non-Small Cell Lung Cancer by Prophylactic Cranial Irradiation
por: Witlox, Willem J. A., et al.
Publicado: (2018)

Prophylactic cranial irradiation or MRI surveillance for extensive stage small cell lung cancer
por: Taylor, James M., et al.
Publicado: (2020)

Prophylactic cranial irradiation in non-small cell lung cancer: evidence and future development
por: Chalubinska-Fendler, Justyna, et al.
Publicado: (2021)

Hippocampal avoidance in prophylactic cranial irradiation for small cell lung cancer: benefits and pitfalls
por: Abraham, Aswin George, et al.
Publicado: (2021)

Safe administration of etoposide phosphate after hypersensitivity reaction to intravenous etoposide
por: Siderov, J, et al.
Publicado: (2002)

Beyond First-Line Immunotherapy: Potential Therapeutic Strategies Based on Different Pattern Progressions: Oligo and Systemic Progression
por: Prelaj, Arsela, et al.
Publicado: (2021)

MON-916 Pure Large Cell Neuroendocrine Carcinoma (LCNEC) of the Gall Bladder in a Patient with Down Syndrome - a Rare Case of an Aggressive Tumor of the Gall Bladder
por: Azmath, Misbah, et al.
Publicado: (2020)

Prophylactic cranial irradiation in non-small cell lung cancer patients: who might be the candidates?
por: Dimitropoulos, Charalampos, et al.
Publicado: (2011)

Prophylactic cranial irradiation in patients with small-cell lung cancer: the experience at the Institute of Oncology Ljubljana
por: Stanic, Karmen, et al.
Publicado: (2010)

Prophylactic cranial irradiation in small cell lung cancer: a systematic review and meta-analysis
por: Yin, Xin, et al.
Publicado: (2019)

Prophylactic cranial irradiation in small-cell lung cancer: update on patient selection, efficacy and outcomes
por: Manapov, Farkhad, et al.
Publicado: (2018)

Prophylactic Cranial Irradiation for Extensive-Stage Small-Cell Lung Cancer: A Retrospective Analysis
por: Matutino, Adriana, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0ep70k7el4p0iic1m8l1d7o2il